Innovative Strategies for Enhancing Topical and Transdermal Drug Delivery

Abstact: Historically, the skin was thought to be a simple homogenous barrier. However, it is now known to be a highly specialised organ, and plays a key role in homeostasis. The protective properties of the skin are provided by the outermost layer, the epidermis, which safeguards against chemical, microbial, and physical attack. The exceptional barrier properties of the skin result in it being a challenging route for the delivery of therapeutic agents. This article reviews strategies developed to enhance the skin penetration of drugs, ranging from conventional approaches, for example the use of chemical penetration enhancers to those in early-stage development, such as microscissioning.

[1]  T. Tsai,et al.  Transdermal delivery of tea catechins and theophylline enhanced by terpenes: a mechanistic study. , 2007, Biological & pharmaceutical bulletin.

[2]  Kanji Takada,et al.  Feasibility of microneedles for percutaneous absorption of insulin. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  M. Heit,et al.  Transdermal lontophoretic Delivery of Luteinizing Hormone Releasing Hormone (LHRH): Effect of Repeated Administration , 1994, Pharmaceutical Research.

[4]  Chung-Hong Hu,et al.  Transdermal delivery of macromolecules by erbium:YAG laser. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Akira Kato,et al.  Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride , 1987, The Journal of pharmacy and pharmacology.

[6]  Wijaya Martanto,et al.  Transdermal Delivery of Insulin Using Microneedles in Vivo , 2004, Pharmaceutical Research.

[7]  P. Paronen,et al.  Interaction of liposomes with human skin in vitro--the influence of lipid composition and structure. , 1996, Biochimica et biophysica acta.

[8]  M. Hussain,et al.  Contributions of Drug Solubilization, Partitioning, Barrier Disruption, and Solvent Permeation to the Enhancement of Skin Permeation of Various Compounds with Fatty Acids and Amines , 1990, Pharmaceutical Research.

[9]  M. Ashburn,et al.  A Pilot Study Assessing the Impact of Heat on the Transdermal Delivery of Testosterone , 2001, Journal of clinical pharmacology.

[10]  F. Tse,et al.  Effect of Current Magnitude and Drug Concentration on lontophoretic Delivery of Octreotide Acetate (Sandostatin®) in the Rabbit , 1994, Pharmaceutical Research.

[11]  Adrian C. Williams,et al.  Can drug‐bearing liposomes penetrate intact skin? , 2006, The Journal of pharmacy and pharmacology.

[12]  Sion A. Coulman,et al.  Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. , 2006, Current drug delivery.

[13]  Mark G. Allen,et al.  Hollow metal microneedles for insulin delivery to diabetic rats , 2005, IEEE Transactions on Biomedical Engineering.

[14]  E. Peira,et al.  Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. , 2002, International journal of pharmaceutics.

[15]  H. Benson Transfersomes for transdermal drug delivery , 2006, Expert opinion on drug delivery.

[16]  R. Guy,et al.  Transdermal drug delivery : developmental issues and research initiatives , 1989 .

[17]  W. J. Irwin,et al.  Phonophoresisis it a reality , 1995 .

[18]  J. Hadgraft Skin, the final frontier. , 2001, International journal of pharmaceutics.

[19]  Y. Kalia,et al.  Transdermal Iontophoretic Delivery of Vapreotide Acetate AcrossPorcine Skin in Vitro , 2005, Pharmaceutical Research.

[20]  W. Wohlrab,et al.  The effect of liposomal incorporation of topically applied hydrocortisone on its serum concentration and urinary excretion. , 1989, Dermatologische Monatschrift.

[21]  E. Peira,et al.  Deformable liposomes for dermal administration of methotrexate. , 2004, International journal of pharmaceutics.

[22]  B. W. Barry,et al.  Limitations of hairless mouse skin as a model for in vitro permeation studies through human skin: hydration damage. , 1988, The Journal of investigative dermatology.

[23]  Adrian C. Williams,et al.  Penetration enhancers. , 2004, Advanced drug delivery reviews.

[24]  Gary P. Martin,et al.  Dermal and Transdermal Drug Delivery Systems: Current and Future Prospects , 2006, Drug delivery.

[25]  S. Majumdar,et al.  Topical delivery of N-alkyl-N-alkyloxycarbonylaminomethyl (NANAOCAM) prodrugs of theophylline (ThH). , 2007, International journal of pharmaceutics.

[26]  S. Singh,et al.  Transdermal drug delivery by passive diffusion and iontophoresis: A review , 1993, Medicinal research reviews.

[27]  Y. Chien,et al.  Controlled drug release from polymeric delivery devices V: Hydroxy group effects on drug release kinetics and thermodynamics. , 1979, Journal of pharmaceutical sciences.

[28]  J. W. Wiechers,et al.  The barrier function of the skin in relation to percutaneous absorption of drugs , 1989, Pharmaceutisch Weekblad.

[29]  Jagdish Singh,et al.  Passive and iontophoretic transport enhancement of insulin through porcine epidermis by depilatories: Permeability and fourier transform infrared spectroscopy studies , 2008, AAPS PharmSciTech.

[30]  Priya Batheja,et al.  Transdermal iontophoresis. , 2006, Expert opinion on drug delivery.

[31]  J. Tsai,et al.  Tape stripping and sodium dodecyl sulfate treatment increase the molecular weight cutoff of polyethylene glycol penetration across murine skin , 2003, Archives of Dermatological Research.

[32]  R. Stoughton Enhanced percutaneous penetration with 1-dodecylazacycloheptan-2-one. , 1982, Archives of dermatology.

[33]  T. Senderovitz,et al.  Pharmacokinetics and Pharmacodynamics of a New Formulation of Recombinant Human Growth Hormone Administered by ZomaJet 2 Vision, a New Needle‐Free Device, Compared to Subcutaneous Administration Using a Conventional Syringe , 2002, Journal of clinical pharmacology.

[34]  Mark R Prausnitz,et al.  Precise microinjection into skin using hollow microneedles. , 2006, The Journal of investigative dermatology.

[35]  Mark R Prausnitz,et al.  Microneedles for transdermal drug delivery. , 2004, Advanced drug delivery reviews.

[36]  E. Shefter,et al.  Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides , 1986 .

[37]  O. Abdallah,et al.  Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. , 2006, International journal of pharmaceutics.

[38]  I. Sugimoto,et al.  Enhancement of transdermal delivery by superfluous thermodynamic potential. I. Thermodynamic analysis of nifedipine transport across the lipoidal barrier. , 1987, Journal of pharmacobio-dynamics.

[39]  A. Brodin,et al.  Drug release studies on an oil-water emulsion based on a eutectic mixture of lidocaine and prilocaine as the dispersed phase. , 1986, Journal of pharmaceutical sciences.

[40]  A. Michaels,et al.  Drug permeation through human skin: Theory and invitro experimental measurement , 1975 .

[41]  N. A. Megrab,et al.  Oestradiol permeation through human skin and silastic membrane : effects of propylene glycol and supersaturation , 1995 .

[42]  Henry,et al.  Microfabricated microneedles: A novel approach to transdermal drug delivery , 1999, Journal of pharmaceutical sciences.

[43]  N. Weiner,et al.  The influence of particle size of liposomes on the deposition of drug into skin , 1994 .

[44]  Mark G. Allen,et al.  Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Johan Moan,et al.  Topical Application of 5-Aminolevulinic Acid Hexyl Ester and 5-Aminolevulinic Acid to Normal Nude Mouse Skin: Differences in Protoporphyrin IX Fluorescence Kinetics and the Role of the Stratum Corneum¶ , 2000, Photochemistry and photobiology.

[46]  R. Heine,et al.  The Medi‐Jector II: Efficacy and Acceptability in Insulin‐dependent Diabetic Patients With and Without Needle Phobia , 1988, Diabetic medicine : a journal of the British Diabetic Association.

[47]  Andreas G. Schätzlein,et al.  Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. , 1998, Biochimica et biophysica acta.

[48]  Geoffrey Lee,et al.  Drug permeation through human skin II: Permeability of ionizable compounds. , 1984, Journal of pharmaceutical sciences.

[49]  R. Gurny,et al.  Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats. , 2006, Molecular vision.

[50]  S. Jain,et al.  Transfersomes—A Novel Vesicular Carrier for Enhanced Transdermal Delivery: Development, Characterization, and Performance Evaluation , 2003, Drug development and industrial pharmacy.

[51]  M. Foldvari,et al.  Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. , 1990, Journal of microencapsulation.

[52]  Jagdish Singh,et al.  Electronically facilitated transdermal delivery of human parathyroid hormone (1-34). , 2003, International journal of pharmaceutics.

[53]  Taravat Ghafourian,et al.  The effect of penetration enhancers on drug delivery through skin: a QSAR study. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[54]  G. Somers,et al.  PERCUTANEOUS ABSORPTION , 1956, The Journal of pharmacy and pharmacology.

[55]  Nicholas A Peppas,et al.  Microfabricated drug delivery devices. , 2005, International journal of pharmaceutics.

[56]  Howell G. M. Edwards,et al.  Fourier transform raman spectroscopy of interactions between the penetration enhancer dimethyl sulfoxide and human stratum corneum , 1995 .

[57]  Xun Sun,et al.  Enhanced liver targeting by synthesis ofN1-stearyl-5-Fu and incorporation into solid lipid nanoparticles , 2003, Archives of pharmacal research.

[58]  R. Scheuplein,et al.  Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. , 1967, The Journal of investigative dermatology.

[59]  S. Mitragotri,et al.  Low-frequency sonophoresis: a review. , 2004, Advanced drug delivery reviews.

[60]  M. Ashburn,et al.  Noninvasive drug delivery , 2001, Comprehensive therapy.

[61]  E. Touitou,et al.  Drug delivery across the skin , 2002, Expert opinion on biological therapy.

[62]  K. Sugibayashi,et al.  Effect of the absorption enhancer, Azone, on the transport of 5‐fluorouracil across hairless rat skin , 1985, The Journal of pharmacy and pharmacology.

[63]  W. Wohlrab,et al.  Penetration kinetics of liposomal hydrocortisone in human skin. , 1987, Dermatologica.

[64]  M. Fehr,et al.  Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid. , 2001, Gynecologic oncology.

[65]  M. Roberts,et al.  Ion‐pair Formation as a Strategy to Enhance Topical Delivery of Salicylic Acid , 2000, The Journal of pharmacy and pharmacology.

[66]  Rainer H Müller,et al.  Cosmetic applications for solid lipid nanoparticles (SLN). , 2003, International journal of pharmaceutics.

[67]  B. W. Barry,et al.  Skin absorption enhancers. , 1992, Critical reviews in therapeutic drug carrier systems.

[68]  J. Yoshimitsu,et al.  Self-dissolving microneedles for the percutaneous absorption of EPO in mice , 2006, Journal of drug targeting.

[69]  Q. Ping,et al.  Enhanced transdermal delivery of tetracaine by electroporation. , 2000, International journal of pharmaceutics.

[70]  Samir Mitragotri,et al.  Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets , 2007, Proceedings of the National Academy of Sciences.

[71]  I. H. Blank,et al.  Further observations on factors which influence the water content of the stratum corneum. , 1953, The Journal of investigative dermatology.

[72]  Hongzhuo Liu,et al.  Effect of vehicles and enhancers on the topical delivery of cyclosporin A. , 2006, International journal of pharmaceutics.

[73]  D. Notterman,et al.  Alternative routes of drug administration - Advantages and disadvantages (subject review) , 1997 .

[74]  B. Forbes,et al.  The effect of unsaturated fatty acids in benzyl alcohol on the percutaneous permeation of three model penetrants. , 2005, International journal of pharmaceutics.

[75]  S L Jacques,et al.  Mid-infrared laser ablation of stratum corneum enhances in vitro percutaneous transport of drugs. , 1991, The Journal of investigative dermatology.

[76]  R. Panchagnula,et al.  Physicochemical considerations in the iontophoretic delivery of a small peptide: in vitro studies using arginine vasopressin as a model peptide. , 2003, Pharmacological research.

[77]  A. El‐Kattan,et al.  Enhancement of transdermal drug delivery: chemical and physical approaches. , 2000, Critical reviews in therapeutic drug carrier systems.

[78]  L. Maxwell,et al.  Preanesthetic Medication of Children with Midazolam Using the Biojector Jet Injector , 1995, Anesthesiology.

[79]  Christopher P. Thomas,et al.  Skin penetration enhancement of mefenamic acid by ethanol and 1,8-cineole can be explained by the 'pull' effect. , 2006, International journal of pharmaceutics.

[80]  Takaya Miyano,et al.  Sugar Micro Needles as Transdermic Drug Delivery System , 2005, Biomedical microdevices.

[81]  Eric W. Smith,et al.  The Mystical Effects of Dermatological Vehicles , 2005, Dermatology.

[82]  R. Panchagnula,et al.  Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[83]  Y. Kalia,et al.  Enhanced skin permeation of a lipophilic drug using supersaturated formulations. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[84]  B. Tashtoush,et al.  Azathioprine transport through rat skin and its immunosuppressive effect. , 2004, Die Pharmazie.

[85]  B. W. Barry,et al.  Mechanistic study into the enhanced transdermal permeation of a model beta-blocker, propranolol, by fatty acids: a melting point depression effect. , 2001, International journal of pharmaceutics.

[86]  H. Frasure,et al.  Subcutaneous lidocaine delivered by jet-injector for pain control before IV catheterization in the ED: the patients' perception and preference. , 2002, The American journal of emergency medicine.

[87]  Dinesh Mishra,et al.  Elastic liposomes mediated transcutaneous immunization against Hepatitis B. , 2006, Vaccine.

[88]  S. Shen,et al.  The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil. , 2002, Journal of pharmaceutical sciences.

[89]  Nadine Barrie Smith,et al.  Ultrasound Mediated Transdermal Insulin Delivery in Pigs Using a Lightweight Transducer , 2007, Pharmaceutical Research.

[90]  Edmond Sabo,et al.  Fear of injections in young adults: prevalence and associations. , 2003, The American journal of tropical medicine and hygiene.

[91]  K. Sugibayashi,et al.  Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[92]  Jhi-Joung Wang,et al.  Transdermal delivery of nalbuphine and its prodrugs by electroporation. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[93]  M. Nakano,et al.  Evaluation of percutaneous absorption of midazolam by terpenes. , 2003, Drug metabolism and pharmacokinetics.

[94]  H. Trommer,et al.  Overcoming the Stratum Corneum: The Modulation of Skin Penetration , 2006, Skin Pharmacology and Physiology.

[95]  Aarti Naik,et al.  Iontophoretic drug delivery. , 2004, Advanced drug delivery reviews.

[96]  T. Imai,et al.  Evaluation of Stereoselective Transdermal Transport and Concurrent Cutaneous Hydrolysis of Several Ester Prodrugs of Propranolol: Mechanism of Stereoselective Permeation , 1996, Pharmaceutical Research.

[97]  R. Scheuplein,et al.  Percutaneous absorption of steroids. , 1969, The Journal of investigative dermatology.

[98]  O. Abdallah,et al.  Lipid vesicles for skin delivery of drugs: reviewing three decades of research. , 2007, International journal of pharmaceutics.

[99]  N. A. Megrab,et al.  Oestradiol permeation across human skin, silastic and snake skin membranes: The effects of ethanol/water co-solvent systems☆ , 1995 .

[100]  R. Brodell,et al.  The treatment of palmar and plantar warts using natural alpha interferon and a needleless injector. , 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[101]  Joseph Kost,et al.  Ultrasound and transdermal drug delivery. , 2004, Drug discovery today.

[102]  W H Smart,et al.  The use of silicon microfabrication technology in painless blood glucose monitoring. , 2000, Diabetes technology & therapeutics.

[103]  K. Svendsen,et al.  Irritant cutaneous reactions to N‐methyl‐2‐pyrrolidone (NMP) , 1992, Contact dermatitis.

[104]  Jung-Hwan Park,et al.  Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[105]  J. Karras,et al.  Dermal delivery of topically applied oligonucleotides via follicular transport in mouse skin. , 2005, The Journal of investigative dermatology.

[106]  Vincent J. Sullivan,et al.  Microneedle-Based Intradermal Delivery of the Anthrax Recombinant Protective Antigen Vaccine , 2006, Infection and Immunity.

[107]  A. Singer,et al.  Low-frequency sonophoresis: pathologic and thermal effects in dogs. , 1998, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[108]  S. Shen,et al.  Erbium:YAG laser-mediated oligonucleotide and DNA delivery via the skin: an animal study. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[109]  Brian W. Barry,et al.  Mode of action of penetration enhancers in human skin , 1987 .

[110]  A. Rawlings,et al.  Moisturization and skin barrier function , 2004, Dermatologic therapy.

[111]  Mark R. Prausnitz,et al.  Coating Formulations for Microneedles , 2007, Pharmaceutical Research.

[112]  R. Malone,et al.  Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[113]  M. Fujii,et al.  Enhancement Effect of p‐Menthane‐3,8‐diol on In Vitro Permeation of Antipyrine and Indomethacin Through Yucatan Micropig Skin , 2004, Drug development and industrial pharmacy.

[114]  S. Shen,et al.  In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser. , 2006, Journal of pharmaceutical sciences.

[115]  G. Stagni,et al.  Effects of penetration enhancers on in vitro permeability of meloxicam gels. , 2007, International journal of pharmaceutics.

[116]  K. Knutson,et al.  Mechanism of Ethanol-Enhanced Estradiol Permeation Across Human Skin in Vivo , 1990, Pharmaceutical Research.

[117]  L. Kang,et al.  Reversible effects of permeation enhancers on human skin. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[118]  S. Mitragotri,et al.  Ultrasound-mediated transdermal protein delivery , 1995, Science.

[119]  A. B. Prasad,et al.  British National Formulary , 1994 .

[120]  M. Cormier,et al.  Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. , 2006, Vaccine.

[121]  T. R. Krishnan,et al.  Transdermal delivery of cyclosporin-A using electroporation. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[122]  Y. Matsumoto,et al.  Iontophoretic pulsatile transdermal delivery of human parathyroid hormone (1–34) , 2001, The Journal of pharmacy and pharmacology.

[123]  Adrian C. Williams,et al.  Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes , 2001, The Journal of pharmacy and pharmacology.

[124]  H. Benson,et al.  Ion‐pairs of ibuprofen: increased membrane diffusion , 2004, The Journal of pharmacy and pharmacology.

[125]  A. Wolf,et al.  Rapid skin anaesthesia using high velocity lignocaine particles: a prospective placebo controlled trial , 2002, Archives of disease in childhood.

[126]  T. Desai,et al.  Microfabricated drug delivery systems: from particles to pores. , 2003, Advanced drug delivery reviews.

[127]  G. E. El Maghraby,et al.  Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. , 2000, International journal of pharmaceutics.

[128]  J. Hadgraft,et al.  Percutaneous delivery of carbamazepine and selected N-alkyl and N-hydroxyalkyl analogues. , 2004, International journal of pharmaceutics.

[129]  Nili Grossman,et al.  The nature of ultrasound-SLS synergism during enhanced transdermal transport. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[130]  Chandra Sekhar Kolli,et al.  Characterization of Solid Maltose Microneedles and their Use for Transdermal Delivery , 2007, Pharmaceutical Research.

[131]  E. Young,et al.  Effect of topical vehicle composition on the in vitro release of fluocinolone acetonide and its acetate ester. , 1968, Journal of pharmaceutical sciences.

[132]  J. Eppstein,et al.  Transdermal Delivery of Interferon Alpha-2B using Microporation and Iontophoresis in Hairless Rats , 2007, Pharmaceutical Research.

[133]  A. Tiwary,et al.  Sustained and targeted delivery of an anti-HIV agent using elastic liposomal formulation: mechanism of action. , 2006, Current drug delivery.

[134]  J. Hadgraft,et al.  The selection and design of topical and transdermal agents: a review. , 1998, The journal of investigative dermatology. Symposium proceedings.

[135]  A. Tedesco,et al.  Oleic Acid as Optimizer of the Skin Delivery of 5-Aminolevulinic Acid in Photodynamic Therapy , 2005, Pharmaceutical Research.

[136]  W. Nimmo The promise of transdermal drug delivery. , 1990, British journal of anaesthesia.

[137]  R. Prankerd,et al.  Transdermal delivery of 5-fluorouracil (5-FU) through hairless mouse skin by 1-alkyloxycarbonyl-5-FU prodrugs: Physicochemical characterization of prodrugs and correlations with transdermal delivery , 1994 .

[138]  J. Hadgraft,et al.  Penetration enhancement of ibuprofen from supersaturated solutions through human skin. , 2001, International journal of pharmaceutics.

[139]  M. G. Rimoli,et al.  In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[140]  R. Potts,et al.  Lipid biophysics of water loss through the skin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[141]  A. Blume,et al.  Interaction of phospholipid liposomes with lipid model mixtures for stratum corneum lipids , 1993 .

[142]  V. Rodilla,et al.  Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[143]  M. Fujii,et al.  Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[144]  Oliver A. Shergold,et al.  The penetration of a soft solid by a liquid jet, with application to the administration of a needle-free injection. , 2006, Journal of biomechanics.

[145]  S. Wissing,et al.  The development of an improved carrier system for sunscreen formulations based on crystalline lipid nanoparticles. , 2002, International journal of pharmaceutics.

[146]  P. Dallas,et al.  Ion Pair Formation as a Possible Mechanism for the Enhancement Effect of Lauric Acid on the Transdermal Permeation of Ondansetron , 2005, Pharmaceutical development and technology.

[147]  N. Dixit,et al.  Iontophoresis - an approach for controlled drug delivery: a review. , 2007, Current drug delivery.

[148]  Gopinathan K Menon,et al.  New insights into skin structure: scratching the surface. , 2002, Advanced drug delivery reviews.

[149]  A. Nokhodchi,et al.  The enhancement effect of surfactants on the penetration of lorazepam through rat skin. , 2003, International journal of pharmaceutics.

[150]  Mark G. Allen,et al.  Polymer Microneedles for Controlled-Release Drug Delivery , 2006, Pharmaceutical Research.

[151]  T. Nevalainen,et al.  Piperazinylalkyl prodrugs of naproxen improve in vitro skin permeation. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[152]  J. Matriano,et al.  Macroflux® Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization , 2004, Pharmaceutical Research.

[153]  Shishu,et al.  Preparation of hydrogels of griseofulvin for dermal application. , 2006, International journal of pharmaceutics.

[154]  J. Bouwstra,et al.  Structural investigations of human stratum corneum by small-angle X-ray scattering. , 1991, The Journal of investigative dermatology.

[155]  Mandip Singh,et al.  Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. , 2002, International journal of pharmaceutics.

[156]  J. M. Marchetti,et al.  In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[157]  N. Weiner,et al.  Topical delivery enhancement with multilamellar liposomes into pilosebaceous units: I. In vitro evaluation using fluorescent techniques with the hamster ear model. , 1992, The Journal of investigative dermatology.

[158]  M. Schäfer-Korting,et al.  Solid lipid nanoparticles as drug carriers for topical glucocorticoids. , 2000, International journal of pharmaceutics.

[159]  L. Strekowski,,et al.  Investigation of Iminosulfuranes as Novel Transdermal Penetration Enhancers: Enhancement Activity and Cytotoxicity , 2005, Pharmaceutical Research.

[160]  C. Legault,et al.  Development of New Jet Injector for Insulin Therapy , 1986, Diabetes Care.

[161]  C. Chiang,et al.  Control of drug crystallization in transdermal matrix system , 1996 .

[162]  Dexiang Chen,et al.  Epidermal powder immunization against influenza. , 2004, Vaccine.

[163]  Regina Luttge,et al.  Silicon micromachined hollow microneedles for transdermal liquid transport , 2003 .

[164]  Huibi Xu,et al.  Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. , 2007, International journal of pharmaceutics.

[165]  A. Fadda,et al.  Niosomes as carriers for tretinoin. I. Preparation and properties. , 2002, International journal of pharmaceutics.

[166]  B. W. Barry,et al.  Novel mechanisms and devices to enable successful transdermal drug delivery. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[167]  R. Guy,et al.  Iontophoretic Delivery of 5-Aminolevulinic Acid (ALA): Effect of pH , 2001, Pharmaceutical Research.

[168]  C. Valenta,et al.  Effects of Penetration Enhancers on the In‐vitro Percutaneous Absorption of Progesterone , 1997, The Journal of pharmacy and pharmacology.

[169]  N. K. Jain,et al.  Ethinylestradiol‐loaded ultraflexible liposomes: pharmacokinetics and pharmacodynamics , 2006, The Journal of pharmacy and pharmacology.

[170]  L. Strekowski,,et al.  Mechanistic studies on percutaneous penetration enhancement by N-(4-halobenzoyl)-S,S-dimethyliminosulfuranes Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/jlr.M500123-JLR200 , 2005, Journal of Lipid Research.

[171]  G. Flynn,et al.  Permeation of Buprenorphine and Its 3-Alkyl-Ester Prodrugs Through Human Skin , 1996, Pharmaceutical Research.

[172]  J. A. Gimm,et al.  Transdermal Delivery of Heparin by Skin Electroporation , 1995, Bio/Technology.

[173]  M. Hussain,et al.  Transdermal oxymorphone formulation development and methods for evaluating flux and lag times for two skin permeation-enhancing vehicles. , 1990, Journal of pharmaceutical sciences.

[174]  T. Higuchi,et al.  Physical Chemical analysis of Percutaneous Absorption Process from Creams and Ointments , 1960 .

[175]  M. Y. Kim,et al.  Skin permeation of retinol in Tween 20‐based deformable liposomes: in‐vitro evaluation in human skin and keratinocyte models , 2006, The Journal of pharmacy and pharmacology.

[176]  D. Monti,et al.  Effect of different terpene-containing essential oils on permeation of estradiol through hairless mouse skin. , 2002, International journal of pharmaceutics.

[177]  Gary P Moss,et al.  Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption , 2006, The Journal of pharmacy and pharmacology.

[178]  S. Kitagawa,et al.  Enhanced skin permeation of diclofenac by ion-pair formation and further enhancement by microemulsion. , 2007, Chemical & pharmaceutical bulletin.

[179]  D. Fuller,et al.  Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device. , 2005, Vaccine.

[180]  B. Müller,et al.  Influence of Supersaturation on the Pharmacodynamic Effect of Bupranolol After Dermal Administration Using Microemulsions as Vehicle , 1992, Pharmaceutical Research.

[181]  R. Baker,et al.  Transdermal delivery of levonorgestrel I: Alkanols as permeation enhancers in vitro , 1988 .

[182]  R. Müller,et al.  Drug delivery to the brain--realization by novel drug carriers. , 2004, Journal of nanoscience and nanotechnology.

[183]  G. Cevc,et al.  Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. , 1992, Biochimica et biophysica acta.

[184]  N. Sadick,et al.  Randomized, Double‐Blind, Placebo‐Controlled Study Evaluating the Lidocaine/Tetracaine Patch for Induction of Local Anesthesia prior to Minor Dermatologic Procedures in Geriatric Patients , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[185]  Melissa Ai Ling Teo,et al.  In Vitro and In Vivo Characterization of MEMS Microneedles , 2005, Biomedical microdevices.

[186]  B. Godin,et al.  Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[187]  E. Touitou,et al.  Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. , 2000, Biomaterials.

[188]  O. Abdallah,et al.  Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. , 2007, Die Pharmazie.

[189]  D. Zurakowski,et al.  A Randomized Controlled Trial to Evaluate S-Caine Patch™ for Reducing Pain Associated with Vascular Access in Children , 2005, Anesthesiology.

[190]  Haidar,et al.  Transdermal testing: practical aspects and methods. , 2000, Pharmaceutical science & technology today.

[191]  E. Eliav,et al.  A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[192]  Wijaya Martanto,et al.  Microinfusion Using Hollow Microneedles , 2006, Pharmaceutical Research.

[193]  G. Cevc,et al.  New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. , 2001, Biochimica et biophysica acta.

[194]  M. Allen,et al.  Lack of Pain Associated with Microfabricated Microneedles , 2001, Anesthesia and analgesia.

[195]  J. Hadgraft,et al.  The dermal delivery of lignocaine: influence of ion pairing. , 2000, International journal of pharmaceutics.

[196]  Y. Kalia,et al.  Passive skin penetration enhancement and its quantification in vitro. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[197]  Adrian C. Williams,et al.  Transdermal and Topical Drug Delivery : From Theory to Clinical Practice , 2003 .

[198]  M. Danhof,et al.  Transdermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[199]  M. Ashburn,et al.  Evaluating skin anesthesia after administration of a local anesthetic system consisting of an S-Caine patch and a controlled heat-aided drug delivery (CHADD) patch in volunteers. , 2000, The Clinical journal of pain.

[200]  E. Zsigmond,et al.  Painless intravenous catheterization by intradermal jet injection of lidocaine: a randomized trial. , 1999, Journal of clinical anesthesia.

[201]  B. W. Barry,et al.  Penetration enhancers for human skin: mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds water, n-alcohols, and caffeine. , 1983, The Journal of investigative dermatology.

[202]  E. Touitou,et al.  Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids. , 1997, Journal of pharmaceutical sciences.

[203]  B. Godin,et al.  Enhanced delivery of drugs into and across the skin by ethosomal carriers , 2000 .

[204]  B. Michniak,et al.  Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. , 1999, Drug development and industrial pharmacy.

[205]  Meindert Danhof,et al.  Transdermal Iontophoresis of Rotigotine Across Human Stratum Corneum in Vitro: Influence of pH and NaCl Concentration , 2004, Pharmaceutical Research.

[206]  Yi Yan Yang,et al.  Skin permeation of physostigmine from fatty acids-based formulations: evaluating the choice of solvent. , 2005, International journal of pharmaceutics.

[207]  P. Friedman,et al.  Thirty‐Minute Application of the S‐Caine Peel Prior to Nonablative Laser Treatment , 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[208]  S. Santoyo,et al.  Transdermal Iontophoresis and Skin Retention of Piroxicam from Gels Containing Piroxicam : Hydroxypropyl-β-cyclodextrin Complexes , 2001 .

[209]  K. Higaki,et al.  Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. , 2005, International journal of pharmaceutics.

[210]  E. Fabrizio,et al.  Sharp beveled tip hollow microneedle arrays fabricated by LIGA and 3D soft lithography with polyvinyl alcohol , 2006 .

[211]  Stanley B. Brown,et al.  Comparative in vitro percutaneous penetration of 5‐aminolevulinic acid and two of its esters through excised hairless mouse skin , 2003, Lasers in surgery and medicine.

[212]  M. Rother,et al.  Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial , 2007, Annals of the rheumatic diseases.

[213]  M. Iwaki,et al.  Absorption of indomethacin and its calcium salt through rat skin: effect of penetration enhancers and relationship between in vivo and in vitro penetration. , 1986, Journal of pharmacobio-dynamics.

[214]  Bozena Michniak,et al.  Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[215]  I. Takahashi,et al.  Daily subcutaneous erythropoietin by jet injection in pediatric dialysis patients. , 1995, Nephron.

[216]  K. Nakamura,et al.  Transdermal administration of salmon calcitonin by pulse depolarization-iontophoresis in rats. , 2001, International journal of pharmaceutics.

[217]  M. Rashidi,et al.  The effect of terpene concentrations on the skin penetration of diclofenac sodium. , 2007, International journal of pharmaceutics.

[218]  G. H. Clowes,et al.  ON DICHLOROETHYLSULFIDE (MUSTARD GAS) IV. THE MECHANISM OF ABSORPTION BY THE SKIN , 1919 .

[219]  Y. Kalia,et al.  In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[220]  A. Urtti,et al.  Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[221]  Chong-Kook Kim,et al.  Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. , 2005, Biomaterials.

[222]  R. Guy,et al.  Reverse Iontophoresis as a Noninvasive Tool for Lithium Monitoring and Pharmacokinetic Profiling , 2004, Pharmaceutical Research.

[223]  B. Finnin,et al.  The transdermal revolution. , 2004, Drug discovery today.

[224]  H. Benson,et al.  Transdermal drug delivery: penetration enhancement techniques. , 2005, Current drug delivery.

[225]  B. Bellhouse,et al.  Transdermal and transmucosal powdered drug delivery. , 1999, Critical reviews in therapeutic drug carrier systems.

[226]  S. Tenjarla,et al.  Synthesis and evaluation of N-acetylprolinate esters - novel skin penetration enhancers. , 1999, International journal of pharmaceutics.

[227]  B. W. Barry,et al.  Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique. , 1988, The Journal of investigative dermatology.

[228]  Y. Kalia,et al.  Ultrasound-enhanced transdermal transport. , 2003, Journal of pharmaceutical sciences.

[229]  Diane E. Sutter,et al.  Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery , 2002, Nature Medicine.

[230]  Adrian C. Williams,et al.  Terpenes and the Lipid–Protein–Partitioning Theory of Skin Penetration Enhancement , 2004, Pharmaceutical Research.

[231]  B. W. Barry,et al.  Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin , 1987, The Journal of pharmacy and pharmacology.

[232]  Sanyog Jain,et al.  Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. , 2005, International journal of pharmaceutics.

[233]  Q. Ping,et al.  Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier. , 2000, Drug delivery.

[234]  Y. Gross,et al.  A microinfusor device for the delivery of therapeutic levels of peptides and macromolecules , 1997 .

[235]  K. Takayama,et al.  Transdermal delivery of indomethacin by iontophoresis. , 2002, Biological & pharmaceutical bulletin.

[236]  Y. Kawano,et al.  Evaluation of the interaction of surfactants with stratum corneum model membrane from Bothrops jararaca by DSC. , 2006, International journal of pharmaceutics.

[237]  Susan F. Paparella Transdermal patches: an unseen risk for harm. , 2005, Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association.

[238]  Shao Jun Jiang,et al.  Examination of the mechanism of oleic acid-induced percutaneous penetration enhancement: an ultrastructural study. , 2003, Biological & pharmaceutical bulletin.

[239]  N. Weiner,et al.  Topical delivery of ciclosporin: evaluation of various formulations using in vitro diffusion studies in hairless mouse skin. , 1990, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[240]  Dorian Liepmann,et al.  Clinical microneedle injection of methyl nicotinate: stratum corneum penetration , 2005, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[241]  Ju-Hyun Kim,et al.  Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix. , 2002, International journal of pharmaceutics.

[242]  R. Stout,et al.  Studies on the use of needle-free injection device on proteins. , 2005, Journal of chromatography. A.

[243]  Samir Mitragotri,et al.  Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis. , 2003, Biophysical journal.

[244]  S. B. Tiwari,et al.  Investigation into the potential of iontophoresis facilitated delivery of ketorolac. , 2003, International journal of pharmaceutics.

[245]  Véronique Préat,et al.  Topical Gene Transfer into Rat Skin Using Electroporation , 2004, Pharmaceutical Research.

[246]  I. Power,et al.  Fentanyl HCl iontophoretic transdermal system (ITS): clinical application of iontophoretic technology in the management of acute postoperative pain. , 2007, British journal of anaesthesia.

[247]  Murthy Sn,et al.  Magnetophoresis: an approach to enhance transdermal drug diffusion. , 1999 .

[248]  Y-P Fang,et al.  Enhancement of topical 5‐aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation , 2004, The British journal of dermatology.

[249]  O. Pillai,et al.  Transdermal Iontophoresis of Insulin , 2004, Skin Pharmacology and Physiology.

[250]  D. Rabussay,et al.  Topical Delivery of Lidocaine in Healthy Volunteers by Electroporation, Electroincorporation, or Iontophoresis: An Evaluation of Skin Anesthesia , 2000, Regional Anesthesia & Pain Medicine.

[251]  B. Godin,et al.  Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[252]  M. Schäfer-Korting,et al.  Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[253]  Bai Xu,et al.  Controlled transdermal delivery of model drug compounds by MEMS microneedle array. , 2005, Nanomedicine : nanotechnology, biology, and medicine.

[254]  C. Rhodes,et al.  Preparation and characterization of liposomes as therapeutic delivery systems: a review. , 1995, Pharmaceutica acta Helvetiae.

[255]  P. Wertz,et al.  Essential fatty acids and epidermal integrity. , 1987, Archives of dermatology.

[256]  Mahmoud Ameri,et al.  Transdermal delivery of desmopressin using a coated microneedle array patch system. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[257]  Jagdish Singh,et al.  Effect of Chemical Penetration Enhancer and Iontophoresis on the In Vitro Percutaneous Absorption Enhancement of Insulin Through Porcine Epidermis , 2005, Pharmaceutical development and technology.

[258]  R. Müller,et al.  Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.

[259]  P. Reddy,et al.  Recent Advances in Novel Drug Delivery Systems , 2003 .

[260]  K. Bain A patient-activated iontophoretic transdermal system for acute pain management with fentanyl hydrochloride: overview and applications. , 2006, Journal of opioid management.

[261]  B. W. Barry,et al.  Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[262]  P. Minghetti,et al.  Polymethacrylates as crystallization inhibitors in monolayer transdermal patches containing ibuprofen. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[263]  Chong-K. Kim,et al.  In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome. , 2004, Biomaterials.

[264]  Göran Stemme,et al.  Novel Microneedle Patches for Active Insulin Delivery are Efficient in Maintaining Glycaemic Control: An Initial Comparison with Subcutaneous Administration , 2007, Pharmaceutical Research.

[265]  M. Mezei,et al.  Liposomes—A selective drug delivery system for the topical route of administration: gel dosage form , 1982, The Journal of pharmacy and pharmacology.

[266]  J. Hadgraft,et al.  Influence of lipophilic counter-ions in combination with phloretin and 6-ketocholestanol on the skin permeation of 5-aminolevulinic acid. , 2003, International journal of pharmaceutics.

[267]  Sanyog Jain,et al.  Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. , 2005, International journal of pharmaceutics.

[268]  R. Scheuplein,et al.  Permeability of the skin. , 1971, Physiological reviews.

[269]  A. Güleç,et al.  Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study , 2005, International journal of dermatology.

[270]  J. Hadgraft,et al.  Mechanisms of action of skin penetration enhancers/retarders: Azone and analogues , 1996 .

[271]  S. Lundin,et al.  Administration of antidiuretic peptide (DDAVP) by way of suction de-epithelialised skin , 1991, The Lancet.

[272]  G. Cevc,et al.  Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes. , 2003, Biochimica et biophysica acta.

[273]  S. González,et al.  Transdermal microconduits by microscission for drug delivery and sample acquisition , 2004, BMC medicine.

[274]  J Hadgraft,et al.  Crystallization of hydrocortisone acetate: influence of polymers. , 2001, International journal of pharmaceutics.

[275]  J Hadgraft,et al.  Membrane penetration enhancement of ibuprofen using supersaturation. , 2000, International journal of pharmaceutics.

[276]  N. Yata,et al.  Enhancement of topical delivery of a lipophilic drug from charged multilamellar liposomes. , 1999, Journal of drug targeting.

[277]  A. Doukas,et al.  Photomechanical transdermal delivery of insulin in vivo , 2001, Lasers in surgery and medicine.

[278]  B. Michniak,et al.  Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin , 2003, AAPS PharmSci.

[279]  Samir Mitragotri,et al.  Current status and future prospects of needle-free liquid jet injectors , 2006, Nature Reviews Drug Discovery.

[280]  P. Elsner,et al.  Skin roughness is negatively correlated to irritation with DMSO, but not with NaOH and SLS , 1997, Experimental dermatology.

[281]  A. Banga,et al.  Electrically Modulated Transdermal Delivery of Fentanyl , 2002, Pharmaceutical Research.

[282]  Dae-Duk Kim,et al.  Synthesis and evaluation of Ketorolac ester prodrugs for transdermal delivery. , 2003, Journal of pharmaceutical sciences.

[283]  S. Scheindlin Transdermal drug delivery: PAST, PRESENT, FUTURE. , 2004, Molecular interventions.

[284]  Yannic B Schuetz,et al.  Emerging strategies for the transdermal delivery of peptide and protein drugs , 2005, Expert opinion on drug delivery.

[285]  J. Bouwstra,et al.  Modes of action of terpene penetration enhancers in human skin; Differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies , 1996 .

[286]  Samir Mitragotri,et al.  Healing sound: the use of ultrasound in drug delivery and other therapeutic applications , 2005, Nature Reviews Drug Discovery.

[287]  M. Fujii,et al.  Application of an oily gel formed by hydrogenated soybean phospholipids as a percutaneous absorption-type ointment base. , 1994, Chemical & pharmaceutical bulletin.

[288]  R. Birnbacher,et al.  Painfulness of needle and jet injection in children with diabetes mellitus , 1994, European Journal of Pediatrics.

[289]  O. Katare,et al.  Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. , 2001, International journal of pharmaceutics.

[290]  S. Lundin,et al.  Absorption of an Oxytocin Antagonist (Antocin) and a Vasopressin Analogue (dDAVP) Through a Standardized Skin Erosion in Volunteers , 1995, Pharmaceutical Research.

[291]  M. Rother,et al.  randomised controlled trial placebo in osteoarthritis of the knee: multicentre and Transfersome®(IDEA-033) versus oral celecoxib Efficacy and safety of epicutaneous ketoprofen in , 2007 .

[292]  A. Sintov,et al.  Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[293]  S. Shen,et al.  Transdermal drug delivery enhanced and controlled by erbium:YAG laser: a comparative study of lipophilic and hydrophilic drugs. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[294]  E. Peira,et al.  Influence of ion pairing on topical delivery of retinoic acid from microemulsions. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[295]  J. Pandit,et al.  Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems. , 2005, International journal of pharmaceutics.

[296]  Y. Kalia,et al.  Electrorepulsion Versus Electroosmosis: Effect of pH on the lontophoretic Flux of 5-Fluorouracil , 1999, Pharmaceutical Research.